Want to see CTHRQ full AI Analyst Report?
Top Page
Rating:―N/A
Price Target:―
Action:N/A
Date:―
No summary available
Positive Factors
Strategic Investment
The $2M investment from Ethara Capital enhances financial stability and governance, potentially supporting long-term strategic initiatives and operational improvements.
Negative Factors
Revenue Decline
A significant decline in revenue indicates challenges in maintaining market share and competitiveness, potentially impacting long-term financial health and growth prospects.
Read all positive and negative factors
Positive Factors
Negative Factors
Strategic Investment
The $2M investment from Ethara Capital enhances financial stability and governance, potentially supporting long-term strategic initiatives and operational improvements.
Read all positive factors
Charles & Colvard (CTHRQ) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.34K
Dividend YieldN/A
Average Volume (3M)9.30K
Price to Earnings (P/E)―
Beta (1Y)-8.60
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees24
SectorConsumer Cyclical
Sector Strength84
IndustryPersonal Products & Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,471,453
10 Day Avg. Volume1,814
30 Day Avg. Volume9,304
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.20
Price to Sales (P/S)0.23
P/FCF Ratio-0.62
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Charles & Colvard Business Overview & Revenue Model
Company Description
Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. It operates through two segments: Online Channels and Traditional. The company manufactures, markets, and distributes moissanite jewels and finish...
How the Company Makes Money
Charles & Colvard generates revenue through multiple streams, primarily driven by the sale of loose moissanite gemstones and finished jewelry products. The company markets its products through its own e-commerce website, which allows it to reach c...
Charles & Colvard Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | TTM | Jun 2024 | Sep 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.75M | 21.96M | 29.95M | 43.09M | 39.24M | 29.19M |
| Gross Profit | 2.64M | 5.19M | 4.73M | 20.24M | 18.43M | 7.99M |
| EBITDA | -11.01M | -13.72M | -13.03M | 3.35M | 7.05M | -5.67M |
| Net Income | -11.97M | -14.36M | -19.58M | 2.37M | 12.81M | -6.16M |
Balance Sheet | ||||||
| Total Assets | 20.06M | 40.98M | 48.88M | 69.21M | 64.92M | 48.90M |
| Cash, Cash Equivalents and Short-Term Investments | 1.26M | 4.14M | 10.45M | 15.67M | 21.30M | 13.99M |
| Total Debt | 1.46M | 4.41M | 2.93M | 3.70M | 4.17M | 2.41M |
| Total Liabilities | 10.02M | 15.33M | 9.11M | 9.65M | 9.23M | 7.47M |
| Stockholders Equity | 19.09M | 25.65M | 39.77M | 59.56M | 55.69M | 41.44M |
Cash Flow | ||||||
| Free Cash Flow | -5.46M | -8.32M | -5.16M | -988.11K | 5.99M | -286.79K |
| Operating Cash Flow | -5.49M | -7.37M | -3.88M | 572.55K | 6.47M | 249.19K |
| Investing Cash Flow | -339.55K | -1.04M | -1.28M | -1.56M | -733.47K | -535.98K |
| Financing Cash Flow | -2.30M | 2.30M | -451.81K | 720.50K | 1.09M | 1.90M |
Charles & Colvard Technical Analysis
0.01
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CTHRQ, the sentiment is undefined. The current price of 0.01 is equal to the 20-day moving average (MA) of ―, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a undefined sentiment for CTHRQ.
Charles & Colvard Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $3.23B | 11.81 | 16.01% | 1.47% | 1.35% | 661.25% | |
66 Neutral | $536.62M | 18.66 | 8.19% | 3.01% | 4.83% | 136.40% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
54 Neutral | $303.38M | -4.01 | -69.12% | ― | -9.10% | -15.30% | |
52 Neutral | $134.44M | -4.67 | -37.58% | 21.13% | 6.41% | -893.45% | |
27 Underperform | $6.11M | -2.80 | 16.37% | ― | 16.46% | 73.42% |
* Consumer Cyclical Sector Average
CTHRQ
Charles & Colvard
0.01
-0.30
-95.90%
BGI
Birks & Mayors
0.31
-0.55
-64.14%
FOSL
Fossil Group
5.15
2.08
67.75%
MOV
Movado Group
33.97
15.63
85.24%
SIG
Signet Jewelers
85.30
-7.02
-7.60%
BRLT
Brilliant Earth Group
1.36
-1.42
-51.08%
Charles & Colvard Corporate Events
Executive/Board Changes
Charles & Colvard announces CEO termination, appoints executive chair
Negative
Jan 7, 2026
On January 5, 2026, Charles Colvard’s Board of Directors terminated President and Chief Executive Officer Don O’Connell without cause, marking a significant leadership change at the company. Effective the same day, Board Chair Michael...
Executive/Board ChangesLegal ProceedingsPrivate Placements and FinancingShareholder Meetings
Charles & Colvard Faces Default Notice and Board Changes
Negative
Dec 5, 2025
On June 24, 2025, Charles Colvard, Ltd. entered into a Convertible Secured Note Purchase Agreement with Ethara Capital LLC, issuing a convertible secured note for $2 million. However, on November 25, 2025, the company received a notice of default...
Legal ProceedingsShareholder Meetings
Charles & Colvard Delays Shareholder Meeting Results
Negative
Oct 16, 2025
Charles Colvard, Ltd. held its Annual Meeting of Shareholders on October 13, 2025, focusing on the election of five board nominees. Due to ongoing legal challenges, the company has delayed announcing the meeting results, with plans to file an ame...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―